97 related articles for article (PubMed ID: 19595448)
1. The unchanging mortality gap for people with schizophrenia.
Chwastiak LA; Tek C
Lancet; 2009 Aug; 374(9690):590-2. PubMed ID: 19595448
[No Abstract] [Full Text] [Related]
2. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J
Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447
[TBL] [Abstract][Full Text] [Related]
3. Excess early mortality in schizophrenia.
Laursen TM; Nordentoft M; Mortensen PB
Annu Rev Clin Psychol; 2014; 10():425-48. PubMed ID: 24313570
[TBL] [Abstract][Full Text] [Related]
4. Life expectancy and cardiovascular mortality in persons with schizophrenia.
Laursen TM; Munk-Olsen T; Vestergaard M
Curr Opin Psychiatry; 2012 Mar; 25(2):83-8. PubMed ID: 22249081
[TBL] [Abstract][Full Text] [Related]
5. Mortality in schizophrenia.
Hasnain M; Vieweg WV; Mezuk B
J Psychopharmacol; 2011 Jun; 25(6):846-7. PubMed ID: 21421641
[No Abstract] [Full Text] [Related]
6. All-cause mortality and medication risk factors in schizophrenia: a prospective cohort study.
Tenback D; Pijl B; Smeets H; Os Jv; Harten Pv
J Clin Psychopharmacol; 2012 Feb; 32(1):31-5. PubMed ID: 22198442
[TBL] [Abstract][Full Text] [Related]
7. Mortality and its determinants in people with psychotic disorder.
Suvisaari J; Partti K; Perälä J; Viertiö S; Saarni SE; Lönnqvist J; Saarni SI; Härkänen T
Psychosom Med; 2013 Jan; 75(1):60-7. PubMed ID: 23257931
[TBL] [Abstract][Full Text] [Related]
8. Minding the gap: changes in life expectancy in the Baltic States compared with Finland.
Karanikolos M; Leon DA; Smith PC; McKee M
J Epidemiol Community Health; 2012 Nov; 66(11):1043-9. PubMed ID: 22495775
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.
Baandrup L; Gasse C; Jensen VD; Glenthoj BY; Nordentoft M; Lublin H; Fink-Jensen A; Lindhardt A; Mortensen PB
J Clin Psychiatry; 2010 Feb; 71(2):103-8. PubMed ID: 19895781
[TBL] [Abstract][Full Text] [Related]
10. Mortality in schizophrenia.
Bushe C; Taylor M; Haukka J
J Psychopharmacol; 2012 Sep; 26(9):1285. PubMed ID: 22854648
[No Abstract] [Full Text] [Related]
11. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.
Tiihonen J; Wahlbeck K; Lönnqvist J; Klaukka T; Ioannidis JP; Volavka J; Haukka J
BMJ; 2006 Jul; 333(7561):224. PubMed ID: 16825203
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of antipsychotics: recent controversies and future management.
Fleischhacker WW
J Clin Psychiatry; 2009 Mar; 70(3):e06. PubMed ID: 19317956
[TBL] [Abstract][Full Text] [Related]
14. Income differences in life expectancy: the changing contribution of harmful consumption of alcohol and smoking.
Martikainen P; Mäkelä P; Peltonen R; Myrskylä M
Epidemiology; 2014 Mar; 25(2):182-90. PubMed ID: 24487202
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular aspects of antipsychotics.
Raedler TJ
Curr Opin Psychiatry; 2010 Nov; 23(6):574-81. PubMed ID: 20838345
[TBL] [Abstract][Full Text] [Related]
16. Serious cardiovascular events and mortality among patients with schizophrenia.
Enger C; Weatherby L; Reynolds RF; Glasser DB; Walker AM
J Nerv Ment Dis; 2004 Jan; 192(1):19-27. PubMed ID: 14718772
[TBL] [Abstract][Full Text] [Related]
17. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
[TBL] [Abstract][Full Text] [Related]
18. Successful deinstitutionalization of mental health care: increased life expectancy among people with mental disorders in Finland.
Westman J; Gissler M; Wahlbeck K
Eur J Public Health; 2012 Aug; 22(4):604-6. PubMed ID: 21659387
[TBL] [Abstract][Full Text] [Related]
19. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
Yogaratnam J; Biswas N; Vadivel R; Jacob R
East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
